[6] [7] In individuals already engaging in intense physical training, this may compound cardiovascular risk
The weight loss mechanism differs as well: GLP-1 agonists work through delayed gastric emptying and central appetite suppression, while berberine's weight effects, when present, likely relate to improved insulin sensitivity and metabolic efficiency
It is not FDA-approved for human consumption, and vendors who market it for personal health use operate outside the established legal framework
That is why these injections are used in both type 2 diabetes and obesity management
Sofwave has FDA clearances for skin laxity treatment across multiple areas, including the upper arms, neck, submental region, and brow
Beyond their metabolic benefits, GLP-1 RAs exhibit neuroprotective and psychotropic effects, potentially benefiting mental health conditions like depression and anxiety